Pharma News, 2024

The US Food and Drug Administration (FDA) has accepted Neurocrine Biosciences’ new drug applications (NDAs) for crinecerfont to treat classic congenital adrenal hyperplasia (CAH&...

Sandoz has announced the US Food and Drug Administration (FDA) approval of the ustekinumab (Stelara) biosimilar ustekinumab-ttwe (Pyzchiva) 45 mg/0.5 mL and 90 mg/mL pre-filled...

In yet another legal development surrounding counterfeit HIV drugs, a Florida court has handed down an indictment for the owners of a wholesale distributor that allegedly bought and redistributed $90 ...

Clinical-stage biotech firm Dianthus Therapeutics has shared preclinical data of its investigational agent DNTH103 being tested in in vitro models of generalised myasthenia gravis (gMG) and ch...

Researchers compared people 50 and older who were diagnosed with a first episode of anxiety between 2008 and 2018 with a control group without anxiety.

The FDA granted the antibody drug conjugate (ADC) TUB-040 a fast track designation for the treatment of patients with platinum-resistant high-grade ovarian cancer (PROC), demonstrating...

AbbVie has acquired biotechnology company Celsius Therapeutics in a deal valued at $250m in cash.

The FDA approved SH-105 (Tepylute) prediluted injectable treatment for breast and ovarian cancers.

Nearly 200 people have been charged with participating in healthcare fraud schemes that resulted in $2.75bn in losses.

CytoDyn Inc., a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that its preclinical MASH (NASH; recently re...

Daewoong Pharmaceutical announced on June 28 that it will embark on primate research in collaboration with Bogor Agricultural University (IPB), which boasts Indonesia's top veterinary rese...

Shanghai, China: Hemp oil extracts containing the terpenes β-caryophyllene and α-humulene possess potent analgesic and anti-cancer properties, according to preclinical data published in Fitoterapia:...